AbbVie (ABBV) Total Non-Current Liabilities (2016 - 2025)
Historic Total Non-Current Liabilities for AbbVie (ABBV) over the last 14 years, with Q3 2025 value amounting to $104.9 billion.
- AbbVie's Total Non-Current Liabilities rose 54.16% to $104.9 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $104.9 billion, marking a year-over-year increase of 54.16%. This contributed to the annual value of $101.7 billion for FY2024, which is 1052.43% up from last year.
- As of Q3 2025, AbbVie's Total Non-Current Liabilities stood at $104.9 billion, which was up 54.16% from $105.3 billion recorded in Q2 2025.
- AbbVie's 5-year Total Non-Current Liabilities high stood at $109.9 billion for Q1 2021, and its period low was $89.0 billion during Q1 2023.
- Its 5-year average for Total Non-Current Liabilities is $100.1 billion, with a median of $102.4 billion in 2021.
- As far as peak fluctuations go, AbbVie's Total Non-Current Liabilities soared by 3616.23% in 2021, and later plummeted by 1125.97% in 2022.
- Over the past 5 years, AbbVie's Total Non-Current Liabilities (Quarter) stood at $102.4 billion in 2021, then dropped by 11.26% to $90.9 billion in 2022, then grew by 1.24% to $92.0 billion in 2023, then increased by 10.52% to $101.7 billion in 2024, then increased by 3.16% to $104.9 billion in 2025.
- Its Total Non-Current Liabilities stands at $104.9 billion for Q3 2025, versus $105.3 billion for Q2 2025 and $103.5 billion for Q1 2025.